Integrative exome sequencing and multi-omics analysis elucidates the regulatory role of rare variants in metabolic syndrome.
Combining genetic sequencing with multi-layer analysis reveals how rare gene variants contribute to heart and metabolic disease, opening paths to personalized treatment.
Integrative exome sequencing with multi-omics reveals rare variant contributions to metabolic syndrome pathogenesis, identifying regulatory mechanisms and novel gene candidates as biomarkers or therapeutic targets for cardiometabolic precision medicine. This record was retained from the prior triage attempt for PubMed pipeline handoff.
What the study was
- Study design
- genomic_association_study
- Category
- cardiovascular_metabolic
- Maturity
- Validated
- Journal
- Functional and Integrative Genomics
Why it surfaced
Rare variant exome-multi-omics integration in metabolic syndrome; novel genetic architecture findings with potential precision prescribing implications.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.